Skip to content

The efficacy of transcutaneous auricular Vagus Nerve Stimulation in patients with prolonged disorders of consciousness

The efficacy of transcutaneous auricular Vagus Nerve Stimulation in patients with prolonged disorders of consciousness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092864
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of consciousness

Interventions

control subjects:No intervention
active Group 1:Left auricular region taVNS
active Group 2:Right auricular region taVNS
active Group 3:Bilateral auricular region taVNS

Sponsors

The Second Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for disorders of consciousness in the interpretation of the US Practice Guidelines for Disorders of Consciousness 2018; 2. Age: 18-80 years; 3. Consciousness was in a stable phase (no change in the CRS-R total score) for at least 2 weeks prior to admission; 4. Disorders of consciousness due to stroke or craniocerebral trauma; 5. 28 days after the injury; (vi) Patients with intact skin on the site of the irritation; 6. Family members signing an informed consent form. 7. Family members sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.unstable vital signs; 2. those with infections, ulcers or scarring in the auricle; 3. devices such as artificial pacemakers and cochlear implants installed in the body; 4. previous vagus nerve surgery; 5. deep sedation, e.g., sedation induced by combinations of general anaesthetics (e.g., propofol) or central sedative (e.g., benzodiazepines, opioids).

Design outcomes

Primary

MeasureTime frame
State of consciousness;functional connectivity;

Secondary

MeasureTime frame
noradrenaline;

Countries

China

Contacts

Public ContactLitong Wang

The Second Hospital of Dalian Medical University

litongwanglv@163.com+86 177 0987 6587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026